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Human embryonic stem cells (hESCs) rely on fibro-
blast growth factor and Activin-Nodal signaling to
maintain their pluripotency. However, Activin-Nodal
signaling is also known to induce mesendoderm
differentiation. The mechanisms by which Activin-
Nodal signaling can achieve these contradictory
functions remain unknown. Here, we demonstrate
that Smad-interacting protein 1 (SIP1) limits the
mesendoderm-inducing effects of Activin-Nodal
signaling without inhibiting the pluripotency-main-
taining effects exerted by SMAD2/3. In turn, Acti-
vin-Nodal signaling cooperates with NANOG, OCT4,
and SOX2 to control the expression of SIP1 in hESCs,
thereby limiting the neuroectoderm-promoting
effects of SIP1. Similar results were obtained with
mouse epiblast stem cells, implying that thesemech-
anisms are evolutionarily conserved and may oper-
ate in vivo during mammalian development. Overall,
our results reveal the mechanisms by which Acti-
vin-Nodal signaling acts through SIP1 to regulate
the cell-fate decision between neuroectoderm and
mesendoderm in the progression from pluripotency
to primary germ layer differentiation.
INTRODUCTION
Human embryonic stem cells (hESCs) are pluripotent cells
derived from embryos at the blastocyst stage. Despite an
apparent common origin, hESCs and mouse embryonic stem
cells (mESCs) rely on different signaling pathways to self-renew
and to maintain their pluripotent status. Mouse ESCs rely on
leukemia inhibitory factor and bone morphogenetic protein
(BMP) signaling (Chambers, 2004), whereas hESCs rely on fibro-
blast growth factor (FGF) and Activin-Nodal signaling (Beattie
et al., 2005; Vallier et al., 2005). Indeed, hESCs resemble plurip-
otent stem cells derived from postimplantation mouse embryos
(mouse epiblast stem cells [mEpiSCs]), suggesting that hESCs
and mEpiSCs share a common embryonic identity and pluripo-
tent state (Brons et al., 2007; Tesar et al., 2007). The similarity
between hESCs andmEpiSCs has been reinforced at themolec-ular level by studies showing that in both pluripotent cell types,
Activin-Nodal signaling directly regulates the expression of the
pluripotency factor NANOG through its intracellular effectors
SMAD2/3 and that NANOG in turn blocks neuroectoderm differ-
entiation induced by FGF signaling (Vallier et al., 2009a; Xu et al.,
2008). These results obtained from in vitro studies complement
in vivo observations showing that NODAL is necessary to main-
tain NANOG expression and to prevent precocious neuroecto-
derm differentiation in the mouse epiblast (Camus et al., 2006;
Mesnard et al., 2006). Taken together, these results clarify the
mechanisms by which Activin-Nodal signaling blocks neuroec-
toderm differentiation while maintaining pluripotency of hESCs,
mEpiSCs, and the late epiblast during earlymammalian develop-
ment. However, Activin-Nodal signaling is also known to be
necessary for driving differentiation of pluripotent stem cells
toward mesendoderm, the common progenitor of the definitive
mesoderm and endoderm lineages, in vitro (D’Amour et al.,
2005) and during gastrulation in vivo (Arnold and Robertson,
2009). The mechanisms by which Activin-Nodal signaling
maintains pluripotency without inducing differentiation into
mesendoderm remain unknown. We determined the gene
expression profile of hESCs grown in the presence or absence
of Activin-Nodal signaling, observing that Smad-interacting
protein 1 (SIP1) was one of the most significantly upregulated
genes upon pharmacological inhibition of Activin-Nodal
signaling. SIP1 is a member of the ZFHX1 family of two-handed
zinc finger/homeodomain proteins and was initially discovered
with the yeast two-hybrid system as a binding partner of
SMAD1 and SMAD2/3 (Verschueren et al., 1999). The SIP1
protein contains two zinc finger clusters flanking a homeodo-
main-like segment, a C-terminal-binding-protein binding site,
and a Smad-binding domain (Postigo et al., 2003). Each zinc
finger cluster binds to one CACCT(G) site (Verschueren et al.,
1999) to repress target genes such as E-CADHERIN (Comijn
et al., 2001) andBRACHYURY (Lerchner et al., 2000). In addition,
SIP1 has been implicated in neuroectoderm development in
Xenopus (van Grunsven et al., 2000; van Grunsven et al.,
2007), mice (Van de Putte et al., 2003), chick (Sheng et al.,
2003), and humans, in which heterozygous mutations or dele-
tions of SIP1 cause Mowat-Wilson syndrome (Dastot-Le Moal
et al., 2007). Finally, SIP1 has been shown to antagonize the
transforming growth factor b (TGFb) family signaling pathway,
which includes Activin-Nodal and BMP signaling, by direct inter-
action with the MH2 domain of activated SMAD proteins
(SMAD1, 2, and 3). These findings led us to hypothesize thatCell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc. 59
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hESCs and in mEpiSCs.
To test this hypothesis, we studied the function of SIP1 in plu-
ripotency and early cell-fate decisions of hESCs and mEpiSCs.
Gain- and loss-of-function experiments confirmed that SIP1
has an essential role in both processes, revealing that SIP1 over-
expression enhances neuroectoderm differentiation whereas its
knockdown allows for the expression of mesendodermal genes
induced by Activin-Nodal signaling. We show that SIP1 estab-
lishes equilibrium between neuroectoderm and mesendoderm
differentiation, thus conferring on these hESCs and mEpiSCs
their pluripotent status.
RESULTS
SIP1 Is Upregulated upon Neuroectoderm
Differentiation
We have previously shown that inhibition of Activin-Nodal
signaling in the presence of FGF2 drives differentiation of hESCs
into neuroectoderm (Smith et al., 2008). To explore the under-
lying mechanisms, we performedmicroarray analyses on hESCs
grown for 48 hr in a chemically defined medium (CDM) in the
presence of FGF2 (12 ng/ml) and SB431542 (SB, 10 mM), an
Activin receptor inhibitor. As expected, SB-treatment resulted
in downregulation of known SMAD2/3 target genes such as
LEFTYA, LEFTYB, NODAL, and NANOG, and upregulation of
neural genes such as OLIG3, HOXA1, GBX2, and SIX1
(Figure 1A). We also observed that the expression of SIP1 was
strongly upregulated upon inhibition of Activin-Nodal signaling,
suggesting that SMAD2/3 could repress the transcription of
SIP1 in hESCs. To confirm these observations, we determined
the gene expression profile of hESCs during neuroectoderm
induction (CDM + SB + FGF2) by using quantitative polymerase
chain reaction (QPCR). Neuroectoderm specification (defined as
the unambiguous onset of lineage-specific gene expression)
occurred after 2 days of treatment with SB. This was marked
by the downregulation of pluripotency genes NANOG and
OCT4 accompanied by the upregulation of early neuroectoderm
genes such as GBX2 and HOXA1 (Figure 1B). Expression of
genes marking neural tube development (OLIG3, SOX1, and
SIX1) started later, at day 4 (Figure 1B), suggesting that neuroec-
toderm generated under these conditions followed a normal
sequence of development. SIP1 expression was detected in
pluripotent hESCs (data not shown), but increased by an order
of magnitude after 2 days of neural induction. The marked
increase of SIP1 upon differentiation thus paralleled the expres-
sion of early neuroectoderm markers GBX2 and HOXA1
(Figure 1B). These observations showed that SIP1 expression
is limited by Activin-Nodal signaling in hESCs and suggested
that SIP1 might have a role in the specification and progression
of hESCs along the neural pathway.
SIP1 Overexpression Enhances Neuroectoderm
Differentiation of hESCs
To determine how SIP1 functions in pluripotency and differenti-
ation, we stably overexpressed SIP1 in hESCs and in mEpiSCs.
Fewer SIP1-overexpressing clones were generated as com-
pared to the green fluorescent protein (GFP) control (Figure S1A
available online), suggesting that SIP1 overexpression was60 Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc.antagonistic to hESC and mEpiSC survival or proliferation.
Nevertheless, three SIP1-overexpressing H9 hESC lines (SIP1-
hESCs) and a control GFP-expressing H9 hESC line (GFP-
hESCs) were expanded for further analyses. Growth curves
showed that SIP1-hESCs grew slower than control GFP-hESCs
(Figure S1B), confirming that high levels of SIP1 expression
diminished hESC self-renewal.
We analyzed the levels of pluripotency and differentiation
markers in SIP1-hESCs by using QPCR analysis. SIP1-hESCs
expressed 20- to 30-fold higher levels of SIP1 transcripts than
control GFP-hESCs (Figure 1C, Day 0), a level comparable to
SIP1 expression in wild-type hESCs after 2 days of neural induc-
tion (see Figure 1B). SIP1 overexpression decreased NANOG,
but not OCT4 or SOX2 expression. Conversely, SIP1 overex-
pression increased both early (GBX2 and HOXA1) and later
(OLIG3, SOX1, and SIX1) neuroectoderm marker expression
(Figure 1C, day 0). QPCR analysis of SIP1-hESCs grown on
feeders showed similar results (Figure S1C). Together, these
observations suggest that SIP1 overexpression inhibits pluripo-
tency and instead favors neuroectoderm development.
To explore the function of SIP1 in neuroectoderm develop-
ment, we grew SIP1-hESCs in CDM supplemented with SB +
FGF2. Whereas control GFP-hESCs adopted a stellar
morphology typical of early neural precursors after SB-treat-
ment, SIP1-hESCs displayed a more pronounced neural
morphology with NEUROFILAMENT-positive neurite projections
(Figure 1D). Importantly, SIP1 overexpression also increased
neuroectoderm differentiation of hESCs grown as embryoid
bodies in CDM, showing that SIP1 promotes neural develop-
ment independent of the culture conditions used for inducing
differentiation (Figure S1E). These results were confirmed in an
independent hESC line by overexpressing SIP1 in hSF-6 cells
(Figure S1B and data not shown). Finally, SIP1 overexpression
in mEpiSCs similarly enhanced neuroectoderm differentiation
(Figures S1B and S1F), suggesting that SIP1 function is evolu-
tionarily conserved between human and mouse. Taken
together, these results lead to the hypothesis that SIP1 plays
a key role in neuroectoderm development in vitro as it does
in vivo.
SIP1 Is Required for Neuroectoderm Differentiation
of hESCs
Accordingly, we carried out loss-of-function experiments,
knocking down SIP1 in hESCs with shRNA. More colonies
were generated by transfecting hESCs with SIP1 shRNA vectors
thanwith a control nontargeting scrambled shRNA vector in both
H9 and hSF-6 lines (Figure S2A), suggesting that SIP1 knock-
down has a positive effect on hESC pluripotency or self-renewal.
Three H9 lines expressing shRNA against SIP1 (shSIP1-hESCs)
and one control line (shScrambled-hESCs) were analyzed.
QPCR showed that expression of SIP1 was knocked down by
90% in shSIP1-hESCs. Expression of the pluripotency marker
NANOG increased by 1.5-fold in SIP1 knockdowns, whereas
expression of OCT4 and SOX2 remained at control levels
(Figure 2A, day 0). In addition, knockdown of SIP1 also
decreased the basal levels of early (GBX2 and HOXA1) and later
(OLIG3 and SOX1) neuroectoderm genes in hESCs (Figure 2A,
day 0). Together, these results corroborate the effects of SIP1
overexpression, showing its proneural effects.
Figure 1. Inhibition of Activin-Nodal
Signaling Induces SIP1 Expression and
Neuroectoderm Differentiation of hESCs
(A) Microarray gene expression heat map of
control hESCs (AF1-AF3) versus hESCs grown in
CDM + 10 mM SB431542 (SB) + 12 ng/ml FGF2
for 2 days (SB1-SB3). Heat-map colors (red for up-
regulation, blue for downregulation) depict gene
expression in units of standard deviation from
the mean across all samples. The asterisk indi-
cates genes that did not pass a significant differ-
ential regulation threshold with FDR 1% when
global sample group expression profiles were
compared. Part of this data was previously pub-
lished in (Vallier et al., 2009a). All raw microarray
data are publicly available from the ArrayExpress
data repository under accession number E-MEXP-
1741 (http://222.ebi.ac.uk).
(B) Gene expression levels in hESCs during neuro-
ectoderm differentiation (CDM + SB + FGF2) were
determined by QPCR. Data represent the mean of
three independent experiments. Error bars indi-
cate standard deviation.
(C) Gene expression levels in GFP-hESCs and
SIP1-hESCs (SIP1.1–SIP1.3) during neuroecto-
derm differentiation (CDM + SB + FGF2) were
determined by QPCR. The asterisk indicates that
all SIP1 lines showed significantly different gene
expression (p % 0.05) compared to control GFP
line.
(D) Immunostaining for NEUROFILAMENT in
control GFP-hESCs (Control) and SIP1-hESCs
(SIP1.1 and SIP1.2) grown for 7 days in CDM +
SB + FGF2. The bottom row shows Hoechst-
stained nuclei.
See also Figure S1.
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SIP1 Mediates Neuroectoderm and MesendodermShSIP1-hESCs induced to differentiate into neuroectoderm
(CDM + SB + FGF2) showed decreased expression of NANOG
and OCT4, as did control shScrambled-hESCs and wild-type
hESCs grown under these conditions (Figure 2A and Smith
et al., 2008). Expression of early neuroectoderm markers
(GBX2 and HOXA1) was slightly decreased by SIP1 knockdown,
suggesting that it was involved but not essential for neuroecto-
derm specification. However, expression of later markers
OLIG3, SOX1, and SIX1 was dramatically decreased in
shSIP1-hESCs, suggesting that SIP1 has a more important role
in the progression of neuroectoderm differentiation than on its
initial specification (Figure 2A). These observations were
confirmed by flow cytometry, showing that during neuroecto-
derm induction, fewer cells expressed neural cell adhesionmole-
cule (NCAM) in the absence of SIP1 (Figure 2B). Moreover, when
differentiated as embryoid bodies in CDM, shSIP1-hESCsCell Stem Cell 6, 59–7displayed lower levels of neuroectoderm
markers (SIP1, OLIG3, and SOX1) and
late neural markers (NGN2 and NEU-
ROD1) than controls (Figure S2B). Impor-
tantly, similar results were obtained
when control shScrambled-hESCs and
shSIP1-hESCs were grown on feeders
and differentiated for 3 days with SB
(Figure S2C), confirming that the effectsof SIP1 knockdown were independent of the culture conditions.
Taken together, these results demonstrate that while SIP1 is not
necessary for initial neuroectoderm specification, it is required
for the normal progression of in vitro neural development.
SIP1 Knockdown Bypasses the Role of Exogenous
Activin
The results described above led us to hypothesize that SIP1
knockdown could bypass the requirement for exogenous Activin
to block neuroectoderm differentiation. Accordingly, shSIP1-
hESCs and control shScrambled-hESCs were grown in CDM
without Activin for 6 days and analyzed for the expression of
pluripotency and differentiation markers by QPCR. In the
absence of exogenous growth factors, control hESCs differenti-
ated into neuroectoderm as shown by the downregulation of
NANOG and OCT4 and upregulation of SIP1, SIX1, and SOX1.0, January 8, 2010 ª2010 Elsevier Inc. 61
Figure 2. SIP1 Is Required for Neuroecto-
derm Differentiation
(A)Geneexpression levels in control shScrambled-
hESCs and shSIP1-hESCs (shSIP1_A – shSIP1_C)
during neuroectoderm differentiation (CDM+SB +
FGF2) were determined by QPCR.
(B) Effects of SIP1 knockdown on the percentage
of NCAM+ cells after neuroectoderm differentia-
tion (CDM + SB + FGF2) was determined by flow
cytometry.
(C) Gene expression levels in shScrambled-
hESCs and shSIP1-hESCs (shSIP1_A – shSIP1_C)
grown in CDM alone were determined by QPCR.
Statistical analyses were as in Figure 1. * indicates
p% 0.05 for all shSIP1 lines compared to control
shScrambled line.
See also Figure S2.
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SIP1 Mediates Neuroectoderm and MesendodermIn contrast, shSIP1-hESCs retained the expression of NANOG
and OCT4, whereas expression of neural markers SIX1, SOX1,
and endogenousSIP1 itself was almost undetectable (Figure 2C).
Similar results were obtained by knocking down SIP1 in hSF-6
hESCs, confirming that these effects are independent of the
cell line used (Figure S2D). Together, these results show that
absence of SIP1 blocks neuroectoderm differentiation induced
by decreasing Activin-Nodal pathway activity.
SIP1 Blocks BMP-Induced Mesendoderm Fates
during Neuroectoderm Differentiation
In amphibians, SIP1 protein is known to interact with SMAD1 and
promote neuroectoderm specification by inhibiting BMP
signaling (Nitta et al., 2004). Consequently, the neuroecto-
derm-enhancing effects of SIP1 in hESCs could be due to
blockade of the inhibitory role of BMP signaling on neuro-62 Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc.ectoderm differentiation. Because BMP
signaling is not active in hESCs grown in
CDM + Activin + FGF (Vallier et al.,
2005), we analyzed the effect of SIP1
overexpression on extra-embryonic
differentiation induced by BMP4 (Fig-
ure 3A and Figure S3A) (Vallier et al.,
2009b; Xu, 2006). QPCR showed that
SIP1-hESCs grown in CDM + BMP4
expressed higher levels of extraembry-
onic tissues markers such as CDX2 and
HAND1 (for trophectoderm) and SOX7
(for primitive endoderm) than control
GFP-hESCs (Figure 3A), suggesting that
SIP1 promotes extraembryonic differ-
entiation induced by BMP4 rather than
inhibiting it. In addition to inducing this
apparent extraembryonic phenotype,
BMP4 increases the basal expression of
definitive mesendoderm and endoderm
markers in hESCs (BRACHYURY,
GOOSECOID, and SOX17). SIP1-hESCs
expressed lower levels of mesendoderm
and endoderm markers, suggesting that
although SIP1 enhances the effect ofBMP signaling on the expression of extra-embryonic genes,
it reduces the expression of mesendodermal and definitive
endodermal genes.
We further investigated the importance of SIP1 on the effect of
BMP signaling in the context of neuroectoderm differentiation.
ShSIP1-hESCs and control shScrambled-hESCs were grown
in neuroectoderm-inducing conditions (CDM + SB + FGF2) for
3 days, followed by treatment with BMP4 for three additional
days. QPCR analyses showed that the addition of BMP4 to
control shScrambled-hESCs decreased the levels of neuroecto-
derm markers SOX2, GBX2, OLIG3, and SOX1 (Figure 3B),
confirming the inhibitory effect of exogenous BMP on neuroecto-
derm differentiation. However, BMP4 treatment did not restore
the expression of pluripotency genes NANOG and OCT4, sug-
gesting that BMP4 addition in such cultures did not revert neuro-
ectodermal cells to the pluripotent state. When BMP4 was
Figure 3. SIP1 Blocks Mesendoderm-Inducing Effects of BMP
during Neuroectoderm Differentiation but Does Not Block
BMP-Induced Extraembryonic Differentiation in hESCs
(A) Gene expression levels in GFP-hESCs and SIP1-hESCs (SIP1.1–SIP1.3)
during extraembryonic induction (CDM + 10 ng/ml BMP4) were determined
by QPCR. *p% 0.05 for all SIP1 lines compared to GFP control.
(B) Gene expression levels in shScrambled-hESCs (SCR) and shSIP1-hESCs
(sh_A and sh_B) grown in CDM + Activin + FGF2 (Untreated), in CDM + SB +
FGF2 (Neuro) for 3 days, or in CDM + SB + FGF2 for 3 days and subsequently
in CDM+BMP4 for 3 days (Neuro + BMP) were determined by QPCR.
Statistical analyses were as in Figure 1.
See also Figure S3.
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SIP1 Mediates Neuroectoderm and Mesendodermadded to cultures of shSIP1-hESCs undergoing neuroectoderm
differentiation, these showed dramatically increased expression
of genes expressed in the primitive streak (mesendoderm
markers) (BRACHYURY, TBX6, and PDGFRa; Figure 3B)
and of genes important for cardiac mesoderm (HAND1,
MESP2, and GATA4; Figure S3B) as compared to control
shScrambled-hESC. Interestingly, exogenous BMP4 did not
increase the expression of the definitive endoderm marker
SOX17 (Figure S3B) in shScrambled-hESCs or in shSIP-hESCs,
confirming that BMP signaling is not sufficient for inducingendoderm differentiation in the absence of Activin-Nodal
signaling. Taken together, these results demonstrate that SIP1
knockdown enables the mesendoderm-inducing effect of BMP
to predominate even after initiation of neuroectoderm differenti-
ation, thereby revealing a role of SIP1 in protecting neural
differentiation from the effects of BMP.
SIP1 Prevents Activin-Nodal Signaling from Driving
Pluripotent hESCs into the Mesendoderm Lineage
SIP1 protein has been shown to inhibit the transcriptional activity
associated with the Activin-Nodal signaling cascade through its
interaction with SMAD2/3 proteins (Verschueren et al., 1999).
Consequently, we investigated whether such a mechanism
could potentially account for the observed effects of SIP1 over-
expression and knockdown described here. We first analyzed
the effects of SIP1 expression on the activity of SBE4-luc, a
luciferase reporter gene specific for Activin-Nodal signaling.
Overexpression of SIP1 decreased SBE4-luc reporter activity,
while knockdown of SIP1 using shRNA increased it. In addition,
SIP1 overexpression limited the potent transcriptional activation
associated with transient SMAD3 overexpression, whereas SIP1
knockdown further stimulated it (Figure 4A). Finally, SIP1 overex-
pression in hESCs decreased the expression of knownSMAD2/3
target genes, such as NANOG, NODAL, LEFTYA, and LEFTYB,
whereas SIP1 knockdown increased their expression (Figure S4).
Together, these data confirm that SIP1 inhibits the transcrip-
tional activity of Activin-Nodal signaling in hESCs.
Because SIP1 limits Activin-Nodal signaling, we hypothesized
that SIP1 prevents this signaling cascade from driving pluripo-
tent stem cells into the mesendoderm (precursor of mesoderm
and endoderm) and definitive endoderm lineages. We thus
investigated the effects of SIP1 knockdown in hESCs cultured
in the presence of a high dose of Activin. ShScrambled-hESCs
and shSIP1-hESCs were grown for 4 days in CDM with different
Activin doses (10 ng/ml and 100 ng/ml). QPCR analyses showed
that shSIP1-hESCs expressed moderately higher levels of the
pluripotency marker NANOG and dramatically higher levels of
mesendoderm and endoderm markers (BRA, MIXL1, EOMES,
GSC, and SOX17) as compared to control shScrambled-hESCs
when they were cultured in 10 ng/ml of Activin (the dose capable
of maintaining pluripotency) (Figure 4B, blue bars). Increasing
Activin concentration to 100 ng/ml upregulated the expression
of NANOG, MIXL1, EOMES, GSC, and SOX17 in shScrambled-
hESCs to levels similar to those for shSIP1-hESCs grown in
10 ng/ml of Activin (Figure 4B, maroon bars). High Activin further
upregulated the expression of mesendoderm and endoderm
markers in shSIP1-hESCs above those shown at 10 ng/ml of
Activin. These results suggest that SIP1 expression in pluripotent
hESCs is necessary to block the expression of mesendoderm
and endoderm markers induced by Activin-Nodal signaling.
These results were further confirmed by analyzing the expres-
sion of mesendoderm and endoderm markers (BRACHYURY,
GOOSECOID, and SOX17) in shSIP1-hESCs differentiated into
neuroectoderm (Figure 4C). QPCR analysis revealed that
shSIP1-hESCs expressed higher levels of BRACHYURY and
SOX17 as compared to shScrambled hESCs even during
the early stages of neuroectoderm differentiation (Figure 4C,
day 2), further supporting the hypothesis that endogenous
SIP1 is required in hESCs to block the expression ofCell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc. 63
Figure 4. SIP1 Inhibits Activin-Nodal
Signaling and Activin-Nodal-Dependent
Expression of Mesendodermal Genes in
hESCs
(A) Effect of SIP1 on SMAD transcriptional activity
was determined bymeasuring luciferase activity of
SBE4-luc reporter. Firefly luciferase activity
(normalized to control renilla activity) is expressed
as mean ± standard deviation from three indepen-
dent experiments.
(B)Geneexpression levels in control shScrambled-
hESCs and shSIP1-hESCs (shSIP1_A – shSIP1_C)
grown for 4 days in CDM + FGF2 + Activin (either
10 ng/ml or 100 ng/ml) were determined by QPCR.
(C)Geneexpression levels in control shScrambled-
hESCs and shSIP1-hESCs (shSIP1_A – shSIP1_C)
during neuroectoderm differentiation (CDM + SB +
FGF2) were determined by QPCR. Statistical
analyses were as in Figure 1. *p % 0.05 for all
shSIP1 lines compared to control shScrambled
line.
See also Figure S4.
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SIP1 Mediates Neuroectoderm and Mesendodermmesendoderm and endoderm markers and thereby to preserve
the pluripotent state.
These results were further supported by analysis of the
expression of mesendoderm, endoderm, and extraembryonic
lineage markers in SIP1-hESCs. Indeed, SIP1 overexpression
decreased the background expression of mesendoderm and
endoderm genes (e.g., BRACHYURY, GOOSECOID, and
SOX17) in hESCs, but did not affect the expression of extraem-
bryonic lineage genes (e.g., HAND1 and SOX7) (Figure S1D, day
0), suggesting that SIP1 specifically limits mesendoderm differ-
entiation of hESCs. Taken together, these observations confirm
that SIP1 plays a crucial role in diminishing the expression of
mesendoderm markers induced by Activin-Nodal signaling in
pluripotent stem cells.64 Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc.SIP1 Overexpression Blocks
Activin-Dependent Endoderm
Differentiation and Developmental
Progression
To explore further the inhibitory effect of
SIP1 on the Activin-Nodal signaling
cascade, we determined whether SIP1
would block endoderm differentiation,
which relies on high levels of Activin-
Nodal signaling (D’Amour et al., 2005;
Ninomiya et al., 1999). SIP1-hESCs
were induced to differentiate into defini-
tive endoderm with a chemically defined
protocol that mimics in vivo development
(Vallier et al., 2009b). This protocol first
induces differentiation of hESCs into
mesendodermal cells expressing primi-
tive streak markers BRACHYURY,
MIXL1, EOMESODERMIN, PDGFRa,
and TBX6 and then drives the differentia-
tion of these cells into definitive endo-
derm cells expressing CXCR4, GOOSE-
COID, and SOX17. QPCR analysisshowed that expression of BRACHYURY, a primitive streak
and pan-mesoderm marker, was lower in SIP1-hESCs than
control GFP-hESCs (Figure 5A). This is consistent with studies
of amphibian development showing thatBRACHYURY is directly
repressed by SIP1 (Papin et al., 2002). However, some mesen-
doderm markers (MIXL1, PDGFRa, and EOMESODERMIN)
were expressed at similar levels in SIP1-hESCs as in control
GFP-hESCs. In contrast, expression of definitive endoderm
markers GOOSECOID, CXCR4, and SOX17 was strongly
reduced in SIP1-hESCs (Figures 5A and 5B). This shows that
during mesendoderm induction with this protocol, SIP1 overex-
pression did not block the initial differentiation into mesendoder-
mal cells, but blocked the differentiation of mesendoderm
cells into definitive endoderm. In addition, we observed that
Figure 5. SIP1 Inhibits Activin-Nodal-
Dependent Endoderm Differentiation and
Developmental Progression
(A) Gene expression levels in GFP-hESCs and
SIP1-hESCs (SIP1.1–SIP1.3) during endoderm
induction were determined by QPCR.
(B) Immunostaining for definitive endoderm
marker SOX17 expression in control GFP-hESCs
(GFP) and SIP1-hESCs (SIP1.1 and SIP1.2) grown
in culture conditions inductive for endoderm differ-
entiation for 6 days.
(C) Effects of SIP1 overexpression on definitive
endoderm development into liver cells were deter-
mined by QPCR. Statistical analyses were as in
Figure 1. *p % 0.05 for all SIP1 lines compared
to GFP control.
See also Figure S5.
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the same protocol failed to express SOX17 (Figure S5B),
showing that the role of SIP1 in blocking endoderm development
is evolutionarily conserved between mouse and human. Finally,
the expression of neuroectoderm (SOX2, SOX1, HOXA1, and
CDX2) and extraembryonic markers (CDX2 and SOX7) was not
increased in SIP1-hESCs grown in culture conditions inductive
for endoderm differentiation (Figure S5A), demonstrating that
SIP1 overexpression did not block endoderm specification by
promoting neuroectoderm or extraembryonic differentiation in
these conditions.
To extend these observations to later stages of endoderm
development, we analyzed the effect of SIP1-overexpressionCell Stem Cell 6, 59–7on liver differentiation, taking advantage
of a protocol recently established in our
laboratory (see Supplemental Experi-
mental Procedures). With this protocol,
control GFP-hESCs showed upregulation
of hepatic nuclear factors (HNF4a,
HNF1b, and HNF6), regulators of liver-
specific gene expression. They also
showed upregulation of definitive liver
markers such as ALBUMIN and a-feto
protein (AFP). However, SIP1-hESCs
cultured in these conditions expressed
lower levels of the HNFs as compared
to control GFP-hESCs and showed no
increase in expression of ALBUMIN and
AFP (Figure 5C). Evidently, SIP1 overex-
pression blocks liver differentiation, con-
firming our observations that SIP1 inhibits
endoderm differentiation.
We then defined the effect of SIP1 in
later mesoderm development, specifi-
cally the capacity to differentiate into
cardiac cells during embryoid body (EB)
formation. After 10 days of EB formation,
24% ± 9%of GFP-EBs displayed beating
structures (Figure S5C and Movie S1),
whereas none of the EBs from SIP1-
hESCs were beating. QPCR analysesshowed that expression of cardiac specific homeobox
(NKX2.5), cardiac myosin heavy chain 6 (MYH6), and ventricular
myosin light chain (MLC2V) was considerably upregulated in the
GFP-EBs (Figure S5D) but not in SIP1-overexpressing EBs.
Interestingly, these observations show that overexpression of
SIP1 impedes differentiation to later stages of mesoderm, even
though it did not affect the expression of some mesendoderm
markers during early stages of differentiation (Figure 5A).
Activin-Nodal Signaling Cooperates with NANOG, OCT4,
and SOX2 to Regulate SIP1 Expression in hESCs
SIP1 expression appears to be tightly controlled in hESCs, with
higher levels favoring neuroectoderm and lower levels favoring0, January 8, 2010 ª2010 Elsevier Inc. 65
Figure 6. NANOG Cooperates with OCT4,
SOX2, and SMAD2/3 to Regulate SIP1
Expression in hESCs
(A) Genomic region of the SIP1 gene bound by
NANOG, OCT4, SOX2, and SMAD2/3 in hESCs
as detected by ChIP. H9 hESCs were grown for
4 days in CDM + Activin + FGF2 and then ChIP
assays were performed with antibodies directed
against NANOG, OCT4, SOX2, and SMAD2/3.
The immunoprecipitated DNA was amplified by
QPCR with specific primers for detection of
enrichment in the denoted regions. Results were
normalized to control region 1 and are shown as
means ± standard derivation from three indepen-
dent experiments.
(B) Effects of SMAD2, NANOG, OCT4, and SOX2
knockdown (KD) or overexpression (OE) on SIP1
expression in hESCs. Statistical analyses were
as in Figure 1. *p = 0.04 and #p = 0.05.
(C) SOX2 (but neither NANOG nor OCT4) showed
sustained binding of the SIP1 promoter during
neuroectoderm differentiation. H9 hESCs were
grown in CDM + Activin + FGF (control) or in
CDM + SB + FGF2 for 3 or 6 days. ChIP-QPCR
was then performed with antibody against
NANOG, OCT4, and SOX2 and primers for SIP1
genomic regions ‘‘8a-10’’ and ‘‘1,’’ denoted as
‘‘enriched’’ and ‘‘control,’’ respectively, on the
basis of NANOG, OCT4, and SOX2 binding
(Figure 6A).
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network controlling SIP1 expression in hESCs. Our observations
that Activin-Nodal inhibition increased SIP1 expression,
whereas a high dose of Activin strongly downregulated SIP1
expression, suggest that SIP1 could be a direct target gene of
Activin-Nodal signaling in hESCs. Furthermore, a previous
genome-wide study showed that NANOG, OCT4 and SOX2
co-occupy the SIP1 promoter (Boyer et al., 2005), suggesting
that SIP1 expression could also be controlled by the core
transcriptional circuitry in hESCs. Accordingly, we performed
chromatin immunoprecipitation (ChIP) analyses to determine
whether SMAD2/3, NANOG, OCT4, and SOX2 were present
on the SIP1 promoter. We observed that SMAD2/3 binds the66 Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc.SIP1 promoter at a region located 5.7 to
6.8 kb upstream of the SIP1 ATG, this
being the same region where NANOG,
OCT4 and SOX2 binding occurs (Fig-
ure 6A). SIP1 expression in hESCs could
thus be directly controlled by these tran-
scription factors. To define precisely the
function of each transcription factor in
the regulation of SIP1 expression, we
individually knocked them down or over-
expressed them in hESCs and then
analyzed the expression of SIP1 by using
QPCR. Decrease in SMAD2, NANOG, or
OCT4 expression each increased SIP1
expression, whereas knockdown of
SOX2 decreased SIP1 expression
(Figure 6B, top row). Conversely, overex-pression of SMAD2, NANOG, or OCT4 decreased SIP1 expres-
sion, whereas overexpression of SOX2 increased SIP1 expres-
sion (Figure 6B, bottom row). These results indicate that
SMAD2, NANOG, and OCT4 repress SIP1 expression, whereas
SOX2 activates its expression. Importantly, only SOX2 binds the
SIP1 promoter during differentiation of hESCs toward the neuro-
ectoderm lineage (Figure 6C), suggesting that SOX2 could favor
neuroectoderm differentiation through the activation of SIP1
expression. Taken together, these results suggest that in
hESCs, SMAD2/3 cooperate with the core transcriptional
circuitry to regulate the expression of SIP1, an important factor
required to block the expression of mesendoderm markers
in pluripotent stem cells and to protect neuroectoderm
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SIP1 Mediates Neuroectoderm and Mesendodermdifferentiation against inhibition by Activin-Nodal and BMP
signaling cascades.
DISCUSSION
The results presented here demonstrate that SIP1 plays an
important role in pluripotency and differentiation of hESCs and
mEpiSCs. Our findings reinforce previous in vivo studies
showing that SIP1 plays a key role in neuroectoderm specifica-
tion (zebrafish, Delalande et al., 2008; Xenopus, van Grunsven
et al., 2000; chick, Sheng et al., 2003; and mouse, Van de Putte
et al., 2003). Importantly, our data show that SIP1 overexpres-
sion enhances neuroectoderm differentiation of hESCs, but its
role in this process is important for progression of neuroecto-
derm development rather than initial specification. This is
supported by our SIP1 knockdown data showing that neuroecto-
derm can be initially specified but is unable to progress to matu-
rity. These data are in agreement with previous genetic studies
carried out in the mouse, which show that SIP1 is neither neces-
sary nor sufficient for initial differentiation of neuroectoderm, but
affects later stages of neural development (Miyoshi et al., 2006).
Several studies have revealed an evolutionarily conserved role
of SIP1 in the inhibition of BMPsignaling (Nitta et al., 2004; Van de
Putte et al., 2003; van Grunsven et al., 2007). Interestingly, in
hESCs grown in chemically defined culture conditions (in which
BMPsignaling is quiescent), SIP1mainly functions to inhibitmes-
endoderm differentiation induced by Activin-Nodal signaling.
Paradoxically, SIP1 enhances, rather than blocks, extraembry-
onic differentiation of hESCs induced by exogenous BMP4.
This could be accounted for by the inhibitory effect of SIP1 on
Activin-Nodal signaling, which in turnmay relieve Activin/Nodal’s
inhibitory effect on BMP signaling, reported by Xu et al. (2008). It
has also been shown that pharmacological inhibition of Activin-
Nodal signaling augments the extraembryonic-lineage-inducing
effect of BMP (Sumi et al., 2008; Vallier et al., 2009b). Therefore,
a SIP1-induced reduction in Activin-Nodal signaling activity as
observed here may actually potentiate the impact of BMP
signaling. Moreover, the differential effects of SIP1 on mesendo-
dermal (BRA and TBX6 affected, but not PDGFRa, MIXL1, or
EOMES) and definitive endoderm marker genes (GSC, SOX17,
and CXCR4 all strongly impeded by SIP1) could be explained
by the differential requirement of Activin-Nodal and BMP
signaling in this cell-fate decision. Accordingly, the more
pronounced effect of SIP1 on endodermal genes could mainly
be due to the greater dependency of this cell-fate decision on
Activin-Nodal signaling, as demonstrated in previous studies
(D’Amour et al., 2005; Nostro et al., 2008; Sumi et al., 2008; Vallier
et al., 2009b). Nonetheless, a role of SIP1 in inhibiting BMP
signaling is observed in the context of neuroectoderm differenti-
ation (in conditions where Activin-Nodal signaling is blocked or
diminished). In this case, SIP1 protects neuroectoderm differen-
tiation from the mesendoderm-inducing effects of BMP. This
supports previous genetic studies demonstrating that SIP1
favors neural induction by blockingmesendoderm differentiation
(Nitta et al., 2007; Papin et al., 2002; Sheng et al., 2003; van
Grunsven et al., 2001; Verschueren et al., 1999). Evidently, SIP1
acts to sustain neuroectoderm differentiation by inhibiting
signaling pathways that induce the formation of other germ
layers, particularly mesendoderm and definitive endoderm.In addition to a role in enhancing neural development, SIP1
plays a key role in maintaining stem cell pluripotency by inhibit-
ing Activin/Nodal-dependent mesendoderm differentiation. This
explains how Activin-Nodal signaling can maintain pluripotency
rather than induce differentiation. We have previously shown
that NANOG interacts directly with SMAD2/3 to limit Activin/
Nodal-induced endoderm differentiation (Vallier et al., 2009a).
Importantly, knockdown of NANOG expression increases neu-
roectoderm markers but not mesendoderm markers, suggest-
ing that another factor (identified here as SIP1) is required to
limit the inductive effect of Activin-Nodal signaling leading to
mesendoderm differentiation. The subsequent developmental
defects of SIP1 in hESCs were demonstrated by their failure
to differentiate into beating cardiomyocytes and by failure of
SIP1-overexpressing hESCs and mEpiSCs to upregulate
SOX17 or differentiate into liver cells. Taken together, our
findings underscore the importance of SIP1 in limiting the endo-
derm-inducing effect of Activin-Nodal signaling, whereby SIP1
balances opposing tendencies toward neuroectodermal and
mesendodermal differentiation, thus preserving the pluripotent
state.
Importantly, our demonstration here of the repression of SIP1
transcription by NANOG provides a missing link between Acti-
vin-Nodal signaling and its inhibition of neuroectoderm differen-
tiation. Our previous demonstration that Activin-Nodal signaling
inhibits neuroectoderm differentiation in hESCs and mEpiSCs
(Vallier et al., 2004a) led to the further mechanistic insight that
this effect is mediated through the activation of NANOG tran-
scription (Vallier et al., 2009a). Specifically, SMAD2/3 bind to
the NANOG promoter and induce NANOG transcription in
hESCs (Vallier et al., 2009a; Xu et al., 2008). Our finding shows
that SMAD2/3, NANOG, and OCT4 repress SIP1 expression in
hESCs, thus revealing the mechanisms by which Activin-Nodal
signaling acts through the pluripotency transcriptional circuit to
prevent differentiation into neuroectodermal fates.
These mechanisms can be summarized in the form of a model
by which Activin-Nodal signaling maintains pluripotency,
preventing neuroectoderm inductionwithout inducingmesendo-
derm differentiation (Figure 7). In pluripotent hESCs, the
transcriptional regulation of SIP1 by Activin-Nodal signaling is
implemented through repressive effects (NANOG and OCT4)
and activating effects (SOX2) that act in opposition to each other,
thereby resulting in a tight regulation of SIP1 expression. This
limits the capacity of SMAD2/3 to activate mesendoderm
markers, but does not block the pluripotency-maintaining effects
of Activin-Nodal signaling. Neuroectoderm specification is trig-
gered by a decrease in Activin-Nodal signaling (which is driven
in embryos by the natural inhibitors of Nodal, Lefty and Cerberus
[Meno et al., 1997; Smith et al., 2008]). The consequent loss of
NANOG and OCT4 expression enables SOX2 to fully activate
theSIP1 gene. Increased SIP1 expression in turn inhibits residual
Activin-Nodal signaling and diminishes the mesendoderm-
inducing effects of BMP signaling. This allows the neuroectoder-
mal cell fate to prevail over mesendodermal fates. This model
reveals how extracellular signals cooperate with the core pluri-
potency transcriptional network to maintain a stasis between
neuroectoderm and mesendoderm differentiation, which is
resolved in favor of neuroectoderm when SIP1 expression
climbs in response to decreased Activin-Nodal activity.Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc. 67
Figure 7. SIP1 Mediates Differentiation of hESCs, Favoring Neuro-
ectoderm and Inhibiting Mesendoderm
During pluripotency, Activin-Nodal signaling drives the expression of NANOG,
which acts together with OCT4 and SMAD2/3 to inhibit expression of SIP1 in
hESCs. NANOG inhibition of neuroectoderm development is achieved through
inhibition of SIP1, whose function is necessary for progression of neural
differentiation. SIP1 inhibits mesendoderm differentiation by diminishing
Activin-Nodal signaling. Inhibition of Activin-Nodal signaling releases the
inhibition of SIP1 expression imposed by SMAD2/3, NANOG and OCT4,
thereby enabling SOX2 to fully activate the transcription of SIP1, which favors
neuroectoderm differentiation, inhibiting mesendoderm differentiation.
Cell Stem Cell
SIP1 Mediates Neuroectoderm and MesendodermIn conclusion, our insight into the function of SIP1 shows how
Activin-Nodal signaling can act both to maintain pluripotency
and to promote mesendoderm differentiation at close develop-
mental intervals. It also offers a mechanism by which the cell-
fate decision to form neuroectoderm is maintained in the face
of stimuli to form other germ layers. Future studies will permit
a thorough understanding of the full molecular cascade by which
SIP1 controls these cell-fate choices, providing knowledge-
based approaches for controlling differentiation of human pluri-
potent cells into clinically useful cell types.
EXPERIMENTAL PROCEDURES
Human ESC and Mouse EpiSC Culture in Chemically Defined
Conditions
Human ESCs (H9 [WiCell, Madison, WI] and hSF-6 [UCSF, San Francisco, CA])
and mouse EpiSCs (129S2-EpiSCs) were grown in a chemically defined
medium (CDM) as previously described (Brons et al., 2007). For neuroecto-
derm differentiation, cells were grown in CDM + SB431542 10 mM (Tocris) +
FGF2 12 ng/ml (R&D systems). For mesendoderm differentiation, cells were
grown in CDM + Activin 100 ng/ml + BMP4 10 ng/ml (R&D Systems) + FGF2
20 ng/ml + LY294002 10 mM (Sigma). For differentiation into extraembryonic
lineages, cells were grown in CDM + BMP4 10 ng/ml. For embryoid body
(EB) formation, hESC colonies were grown in CDM in low attachment plates
(Costar) on a rotating shaker. All differentiation experiments were repeated
at least twice on different passages of cells to ensure that the patterns of
gene expression described were reproducible from one experiment to the
next. See Supplemental Information for cardiac and liver cell differentiation.
Microarray Analysis
Gene expression profiling with microarray has been described in Vallier et al.
(2009a).68 Cell Stem Cell 6, 59–70, January 8, 2010 ª2010 Elsevier Inc.Vectors for Overexpression
The pTP6 vector backbone (Pratt et al., 2000) containing the CAGG
(hCMV/Chicken b-Actin chimeric promoter) promoter and an IRES-Puromycin,
was used as the basis for constructing all expression vectors for stable over-
expression of transgene in hESCs. Flag-SIP1 and YFP-SIP1 (Long et al., 2005)
were subcloned into pTP6 for generating pTP6-Flag-SIP1 and pTP6-YFP-
SIP1. Expression vectors were transfected into hESCs using Lipofectamine
2000 according to Vallier et al. (2004b). pTP6-hrGFP (human recombinant
green fluorescence protein) was used as a transfection control.
Quantitative Polymerase Chain Reaction
Total RNA was extracted with RNeasy Mini kit with a DNase digestion step per
the manufacturer’s instructions (QIAGEN). One microgram of RNA was
reverse-transcribed with Moloney Murine Leukaemia Virus Reverse Transcrip-
tase (GIBCO, 28025-013). Quantitative polymerase chain reaction (QPCR)
mixtures were prepared as described (Quantace Sensimix dT, QT6T3), then
denatured at 94C for 5 min and cycled at 94C for 30 s, 60C for 30 s, and
72C for 30 s; this was followed by final extension at 72C for 10 min after
completion of 40 cycles. QPCR reactions were performed with Stratagene
Mx3005P in duplicate and normalized to Porphobilinogen Deaminase
(PBGD) in the same run. Primer sequences can be found in Tables S2 and
S3. Error bars on all QPCR graphs represent standard deviation from three
independent replicates. Where student’s t tests (two-tailed assuming noneq-
ual variance) were performed, asterisks indicate that all three experimental
lines showed significantly different gene expression (p % 0.05) compared to
control line.
Immunostaining and Flow Cytometry
Detailed immunostaining methods are described in Vallier et al. (2005).
Antibodies used for immunostaining were as follows: Neurofilament, 1:100
(Sigma N2912); SOX17, 1:100 (R&D Systems, AF1924); Cy3-donkey-anti-
mouse IgG, 1:400 (Chemicon, AF192C); and Texas red-donkey-anti-goat
IgG, 1:400 (Jackson Lab, 705-75-147). Antibodies used for flow cytometry
were as follows: NCAM, 1:200 (BD Phamingen, 557699); and mouse IgG
isotype control (BD PharMingen, 555749).
Luciferase Assays
DNA plasmids containing firefly luciferase reporter constructs (SBE4-luc),
CMV-Renilla (Promega), and expression vectors were cotransfected into
hESCs with Lipofectamine 2000 (Invitrogen). The ratio between luciferase
reporters and CMV-Renilla was 10:1. Medium was changed after 18 hr and
cells were harvested 48 hr later for luciferase assay. Luciferase activity was
measured with the dual luciferase assay kit (Promega). Firefly luciferase
activity was normalized to Renilla luciferase activity for cell density and
transfection efficiency.
Knockdown and Cell Sorting
Transient knockdown of OCT4 and SOX2 were carried out with pSilencer-
eGFP. Successfully transfected cells, coexpressing eGFP, were selected by
fluorescence-activated cell sorting (FACS) after 48 hr of growth posttransfec-
tion. Stable knockdown of SIP1, SMAD2, and NANOG were carried out with
pLKO.1-shRNA vector (Sigma) by Lipofectamine transfection. See Table S4
for details.
Chromatin Immunoprecipitation
Detailed chromatin immunoprecipitation methods are described in Vallier et al.
(2009a). Sixteen micrograms of the following antibodies were used for immu-
noprecipitation: SMAD2/3 (Santa Cruz, sc-8332x), NANOG (R&D, AF1997),
SOX2 (R&D, AF2018), and OCT4 (R&D, AF1759). Purified DNA was used as
template for QPCR to amplify the proximal promoter of SIP1. Primer
sequences can be found in Table S5.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, five tables, and one movie and
can be found with this article online at doi:10.1016/j.stem.2009.11.015.
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